Loading...
Practical considerations for the integration of subcutaneous targeted therapies into the oncology clinic
The oncology clinic is changing, with an increasing number of cancer therapies becoming available as formulations for subcutaneous (SC) injection. Using targeted therapies, such as alemtuzumab, bortezomib, rituximab or trastuzumab, via SC injection can be advantageous for patients, healthcare profes...
Na minha lista:
| Udgivet i: | Can Oncol Nurs J |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Canadian Association of Nurses in Oncology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6970019/ https://ncbi.nlm.nih.gov/pubmed/31966017 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|